Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?
Phillip K. Pellitteri(Geisinger Medical Center), WI Wei(First People's Hospital of Foshan), K. Thomas Robbins(University of Tennessee Health Science Center), Alfio Ferlito(University of Udine), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Ashok R. Shaha(Memorial Sloan Kettering Cancer Center), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Luiz Paulo Kowalski(AC Camargo Hospital), Carlos Suárez(Hospital Universitario Central de Asturias), Alessandra Rinaldo(University of Udine), C. René Leemans(Amsterdam UMC Location VUmc), Christine G. Gourin(Johns Hopkins University), Jean Louis Lefèbvre(Centre Oscar Lambret), John Lowry(Royal Bolton Hospital), Jesús E. Medina(University of Oklahoma Health Sciences Center), Eric M. Genden(Icahn School of Medicine at Mount Sinai)
Cited by 83
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
The molecular landscape of head and neck cancer
|Nature reviews. Cancer|2018|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
|Thyroid|2021|699
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
|Journal of Clinical Oncology|2008|687